In 2024, forecasted sales of cardiovascular system medicine in Italy are $57.2 USD per capita, marking a slight downward trend projected to continue through 2028, reaching $55.8 USD per capita. Notably, the year-on-year decline from 2024 to 2025 is approximately 0.87%, with subsequent annual decreases of around 0.7%. The cumulative average growth rate (CAGR) from 2024 to 2028 suggests ongoing slight reductions at a rate of about 0.62% annually.

Future trends to watch for include:

Potential impact of regulatory changes on pharmaceutical pricing.
Advancements in cardiovascular treatments or technologies that may shift consumer demand.
Demographic changes influencing healthcare priorities and spending.